Evidence map›Paper›PMID 32714831›Full record

ArticleIntegrative medicine research2020

Neurofeedback self-regulating training in patients with Post traumatic stress disorder: A randomized controlled trial study protocol.

Jungtae Leem, Moon Joo Cheong, Sang-Hoon Yoon, Hyunho Kim, Hee-Geun Jo, Hyeryun Lee, Jeesu Kim, Hyang Yi Kim, Geun-Woo Kim, Hyung Won Kang

Open access · goldAbstract read
In one paragraph

Article in Integrative medicine research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Efficacy of Neuro-Feedback Training for PTSD Symptoms: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jungtae LeemResearch and Development Institute, CY Pharma Co., Seoul, South Korea.
Moon Joo CheongCollege of Education, Hanyang University, Seoul, South Korea.
Sang-Hoon YoonChung-Yeon Central Institute, Gwangju, South Korea.
Hyunho KimChung-Yeon Central Institute, Gwangju, South Korea.
Hee-Geun JoChung-Yeon Central Institute, Gwangju, South Korea.
Hyeryun LeeDepartment of Korean Neuropsychiatry Medicine, Wonkwang University, Iksan, South Korea.
Jeesu KimDepartment of Korean Neuropsychiatry Medicine, Wonkwang University, Iksan, South Korea.
Hyang Yi KimDepartment of Nursing, Kyung-In Women's University, Incheon, South Korea.
Geun-Woo KimDepartment of Neuropsychiatry, Dongguk University Bundang Oriental Hospital, Seongnam, South Korea.
Hyung Won KangDepartment of Korean Neuropsychiatry Medicine, Wonkwang University, Iksan, South Korea.
Chungwoon University · KRWonkwang University · KRDongguk University · KRHanyang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPost-traumatic stress disorder (PTSD) has become an important public health problem. However, the conventional therapeutic strategy, including pharmacotherapy and cognitive behavioral therapy, has limitations. Neurofeedback is a technique that utilizes electroencephalography (EEG) signaling to monitor human physiological functions and is widely used to treat patients with PTSD. The purpose of our study is to assess the efficacy and safety level of neurofeedback treatment in patients with PTSD using quantitative EEG.

methodsThis is a randomized, waitlist-controlled, assessor-blinded, clinical trial. Forty-six patients with PTSD will be randomly assigned at a 1:1 ratio into two groups. The participants in the treatment group will receive neurofeedback treatment for 50 min, twice a week, for 8 weeks (16 sessions). Quantitative EEG will be utilized to monitor the physiological functions and brain waves of the participants. A four-week follow-up period is planned. The participants in the control group will wait for 12 weeks. The primary outcome is the Korean version of PTSD Checklist-5 (PCL-5-K) score. The PCL-5-K scores on week 8 will be compared between the two groups. Anxiety, depression, insomnia, emotions, EEG, quality-of-life, and safety level will be assessed as secondary outcomes. DISCUSSION: This trial will describe a clinical research methodology for neurofeedback in patients with PTSD. The numerous subjective and objective secondary outcomes add to the value of this trial's results. It will also suggest a therapeutic strategy for utilizing quantitative EEG in patients with PTSD. Our trial will provide basic evidence for the management of PTSD via an integrative treatment.

trial registrationClinical Research Information Service (CRIS): KCT0003271.

Indexed as

NeurofeedbackPost traumatic stress disorderProtocolQuantitative electroencephalographyRandomized controlled trial

Identifiers

PMID32714831
PMCPMC7378693
OpenAlexW3039074679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.